Technical briefings

22 June 2016

Technical briefing Private sector engagement approach pdf

www.gavi.org
Gavi?s 2016 - 2020 private
sector engagement approach
SCALING INNOVATION FOR IMPACT
Gavi Board technical briefing session
21 June 2016 | Geneva, Switzerland
Reaching further, together
A HISTORY OF CREATING SHARED VALUE
PUBLIC PRIVATE PARTNERSHIP WITH VACCINE MANUFACTURERS
VACCINE PRICE
Total cost to immunise
a child with pentavalent, pneumococcal
and rotavirus vaccines (US$)
DIVERSIFICATION
Number of vaccine manufacturers
*Future targets are not publicised to avoid setting a minimum price .
Source: UNICEF Supply Division, 2016.
$35 $33
$23 $22 $22
$20
2010
Baseline
2011 2012 2013 2014 2015
5
2001 2015
16
Manufacturers
in 11 countries
Manufacturers
in 5 countries
SHIFTING MINDSET
Of vaccine manufacturers by
pooling country demand

Board documents

22 June 2016

00a Document list pdf

Board -201 6-Mtg -1-Doc 00 a



G avi Alliance Board Meeting
22 -23 June 2016
Starling Hotel, Geneva, Switzerland
Monday 20 and Tuesday 21 June: Pre -Board meetings
Wednesday 22 June: 0 8.30 -18.00 (Board meeting Day One)
Thursday 23 June: 09.00 -16.45 (Board meeting Day Two)
Quorum: 1 4
Document list
Pack 1 Pack 2 Document
00a Document list
00b 00b Agenda
01a Declarations of interest
01b Minutes from 2-3 December 2015
01c Workplan including 2017 Board meeting dates
02a Consent agenda: Board/Committee member appointments (To follow)
02b Consent agenda: Board Travel Policy review
02c Consent agenda: Gavi Alliance ad -hoc appeals tribunal (To follow)
02d Consent agenda: Programme funding request ? new vaccine support
02e Consent agenda: Oral Cholera Vaccines operationa l cost support
02f Consent agenda: Men A bridg e funding
02g Consent agenda: Co -financing of Japanese Encephalitis vaccine
03 2016 -2020 Strategy: Implementation and progress - No paper
04 CEO?s report (To follow)
05 Committee Chair and IFFIm Board reports ? No paper
06 Gavi -Global Fund approach to collaboration
07 Financial update
08 Report from Audit and Investigations
09 Malaria vaccine pilots
09 Appendix Malaria vaccine pilots ? PPC Paper
10 Chair?s reflections on the day ? No paper
11 Chair?s overview ? No paper
12 Health system and immunisation strengthening support
12 Appendix Health system and immunisation strengthening support ? PPC Paper +
Annexes A , B & C
13 Partners? Engagement Framework & Alliance Accountability Frame work
14 Country Programmes: Sustaining Immunisation Gains ? No paper
15 Supply and procurement strategy 2016 -2020
15 Appendix Supply and procurement strategy 2016 -2020 ? PPC Paper + Annex A & B
16 Review of decisions ? No paper
17 Any other busin ess ? No paper
18 Board and Committee minutes (For information only)

22 June 2016

00b Agenda pdf

Board -2016 -Mtg -1-Doc 00b
`



G avi Alliance Board Meeting
22 -23 June 2016
Starling Hotel, Geneva, Switzerland

Monday 20 and Tuesday 21 June : Pre -Board meetings
Wednesday 22 June : 0 8.30 -18. 00 (Board meeting Day One)
Thursday 23 June : 0 9.00 -16.45 (Board meeting Day Two)
Quorum: 14


Agenda



Pre -Board Meetings ? Monday, 20 June 2016
Item Subject Room Schedule

? IFFIm Donors? workshop Leysin 10.00 -15.30
? AMC Stakeholders? meeting Leysin 16. 15 -18. 15


Pre -Board Meetings ? Tuesday , 21 June 2016
Item Subject Room Schedule

? Technical Briefing Session s
o HPV Demonstration Projects ? Lessons Learnt
Break
o Private Sector Strategy
Break
o Finance
Nendaz 08.30 -13.00
08. 30 -10.00
10.00 -10.15
10.15 -11. 30
11. 30 -11.45
11.45 -13.00
? IFFIm Board Meeting Villars 13.00 -16.45
? Developi ng Countries Board members meeting Montana 13.00 -15. 00
? Governance Committee meeting Arosa 15. 00-17.00
? Board Meeting: Closed session for Board members
and Alternate Board members
Montana 17. 30 -19.00
? Gavi Donors? meeting Nendaz 19.30 -21.30
? Unaffiliat ed Board members dinner 19.30

22 June 2016

01a Declarations of interest pdf

Board-2016-Mtg-1-Doc 01a


Gavi Alliance Board Meeting
22-23 June 2016
Starling Hotel, Geneva, Switzerland

Quorum: 14
Declarations of Interest

Declarations
Section 5.2 of the Conflict of Interest Policy stat es, ?Annually, each member of the Board
(including alternate Board members and Committee de legates)...shall complete and submit a
conflict of interest form to be distributed by the Managing Director, Law and Governance.? The
following declarations were made by members of the Board on their most recent annual
statements:

Board members:
Member Organisational Interests Financial/Personal/Advisor Int
Ngozi Okonjo-Iweala, Chair None Gavi-appointed special adviser
Flavia Bustreo, Vice Chair WHO Gavi-appointed special adviser
Gunilla Carlsson None None
H.R.H. the Infanta Cristina
of Spain None
la Caixa? Foundation (Employee)
Barcelona Inst. for Global Health
(Board)
Aga Khan Dev.Network (Employee)
Yifei Li None Man Group (Country Chair)
Rockefeller Foundation (Board)
Sania Nishtar None None
William H. Roedy None None
Richard Sezibera None Gavi-appointed special adviser
David Sidwell None None
Stephen Zinser None None
Orin Levine Bill & Melinda Gates Foundation PATH (Family)
Tim Evans The World Bank None
Geeta Rao Gupta UNICEF None
Seif Seleman Rashid Government of Tanzania Gavi-appointed special adviser
Khagaraj Adhikari SEARO and WPRO countries Gavi-appointed special adviser
Bahar Idriss Abugarda Government of Sudan Gavi-appointed special adviser
Edna Yolani Batres Government of Honduras Gavi-appointed special adviser
Raymonde Goudou Coffie Government of Cote d?Ivoire Gavi-appointed special adviser
Ingrid Gabriela Hoven GER (EC/FRA/GER/LUX) None

Presentations

22 June 2016

03 2016 2020 Strategy Implementation and progress pdf

Gavi?s 2016 ? 2020 strategic framework
22 June 2016
Gavi 2000 -2015
? Support for 3 vaccines
? Immunisation services support,
injection safety
2000 2005 2006 2010 2011 2015
? 4 vaccines added, incl
rotavirus, pneumococcal
? Health system strengthening
programme started
? Innovative finance
? First co -financing policy
? 12 vaccines in Gavi portfolio
? Acceleration of vaccine introductions
? Proactive market shaping
? First graduation policy
90m children immunised
200 million
children immunised
250 million
children immunised
Gavi 1.0
Gavi 2.0
Gavi 3.0

22 June 2016

04 CEO s report presentation pdf

IMMUNISATION ON THE GLOBAL AGENDA RESULTS UPDATE DELIVERING ON THE NEW STRATEGY
CEO Board presentation
Seth Berkley MD, 22 June 2016
TRANSITION Gavi 3.0 Gavi 4.0
IMMUNISATION ON THE GLOBAL AGENDA RESULTS UPDATE DELIVERING ON THE NEW STRATEGY
IMMUNISATION
ON THE GLOBAL
AGENDA
IMMUNISATION ON THE GLOBAL AGENDA
Board meeting22-23 June 2016

22 June 2016

05f EAC Chair report pdf

www.gavi.org
Evaluation Advisory Committee
Chair Report
BOARD MEETING
Rob Moodie
22 -23 June 2016
Outline
? Ongoing evaluation work to inform priority areas
1. Full Country Evaluations
2. Technical Assistance evaluation
3. HSIS review: designing the evaluation approach
? Use of findings of completed evaluations
? Outcomes & Impact Advance Market Commitment evaluation
? Albania end of Gavi support evaluation
Board meeting22-23 June 2016

22 June 2016

05g IFFIm Chair report pdf

IFFIm update
The International Finance Facility for Immunisation
Ren? Karsenti, Chair IFFIm Board of Directors
22 June 2016 | Geneva
1. Funding Gavi
2. IFFIm?s continued strategic role
3. Replicating IFFIm for Global Goals
2

22 June 2016

06 Gavi Global Fund approach to collaboration pdf

Gavi - Global Fund
approach to collaboration
Gavi and Global Fund at a glance
Mission ? Increase equitable use of vaccines ? Defeat HIV/AIDS , TB and malaria
Core partners
Secretariat size 1 ? ~250 FTEs ? ~650 FTEs
1 Excludes consultants, temps and interns
Board ? 2/3 constituency , 1/3 independent
? Alliance partners voting members
? Fully constituency -based
? Partners have non -voting seats
(Immunisation)
Expenditure ? US$ 1.8bn ( 2015 ) ? US$ 3.5bn ( 2015 )
(HIV, TB & Malaria)

22 June 2016

14b Country Programmes Strengthening Immunisation Programmes pdf

Strengthening Immunization Programs -
Building Health Systems
Gavi / WBG Partnership on Institutional & Financial Sustainability
Gavi Board Meeting, June 22, 2016
? a win -win relationship for sustained results ?
Strengthening
immunization
programs
Building
health
systems
2

22 June 2016

14c Country Programmes Honduras Transition pdf

Minister Dra Yolani Batres
AMRO/EURO Gavi Constituency Representative
Geneva June 2016
Update on Transition: the case of Honduras
GAVI Support for Honduras
Honduras EPI Situation 2011 -2016
Vaccination Scheme and New Vaccine Introduction
Focus of Engagement during Transition Phase
Post - Transition Prospects
Content
Last updated: 24 Nov 2019

Subscribe to our newsletter